Recent Finacing
Recent Raise
Tellus Therapeutics is a preclinical biotech developing TT-20, a breast-milk-derived compound that promotes oligodendrocyte differentiation and myelin repair for neonatal white matter injury, conducting IND-enabling and formulation work.
